Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
[Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
[Immune-mediated neuropathies].
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy.
IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Capacity for financial decision making in multiple sclerosis.
A gut (microbiome) feeling about the brain.
Safety, Tolerability, and Immunogenicity of Interferons.
Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats.
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Peculiarities of Neurological Disorders and Study Designs.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia.
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)].
Opportunities and considerations for visualising neuroimaging data on very large displays.
Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
Products
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.

Pages